Candesic: Alliance of Business and Health Care Expert Consultants

Candesic | Dr Michelle Tempest | Managing Partner
Candesic | Dr Michelle Tempest | Managing Partner

We have reached the time when the healthcare industry has one of the top growths. The work, the technology, and the requirement expanded over a period of time. Organizations in the industry are preparing for the next generation of healthcare services.

There are many challenges faced by the health organizations such as shortage of labour, changes in rules, and customer change in behaviour. On top of that, the pandemic drove the healthcare industry to its lowest state, where the number of patients was more than what the healthcare infrastructure could accommodate. Even precautions of healthcare workers are a priority.

With looking out for daily changes in the industry, healthcare organizations have a lot of things to keep track of, and alongside they have to look out for the health of their patients and the success of the organization.

Healthcare consultants ease the work for healthcare organizations. They do other management work— such as HR, marketing, B2B contracts, people management, and legal affairs—which is required to grow as well as to keep the hierarchy of healthcare organizations running. These consultants have the relevant education and background on healthcare laws, regulations, and policies.

Candesic, a London-based leading strategy consultancy with over 30 consultants and 150 experts, serving private operators, investors, and public sector organizations.

Speaking of giving advice and consultancy, we recently took an interview of an expert healthcare consultant who worked in the industry for more than 18 years, Dr Michelle Tempest, Managing Partner, Candesic.

Read the following interview to gain insights into the healthcare consultancy space and how Dr Tempest is making an impact in it.

Please brief our audience about Candesic, its values, and the key aspects of its stronghold within the healthcare consulting industry.

Candesic was founded 20 years ago by business consultants and medical professionals to bring unmatched sector expertise to help solve complex issues. We are unique in this field as an ethically driven outcome-focused sustainable healthcare consultancy – our purpose is to help our clients make health and care accessible and equitable for all.

Today, our team consists of more than 30 full-time consultants and over 150 experts. We bring cultural and cognitive diversity to our company unmatched by our peers.

Candesic advises global policymakers, NHS, investors (PE and VC), private operators, public hospitals, charities, medical technology, healthcare IT, start-ups and life sciences/ pharmaceutical companies on topics covering healthcare strategy, global expansion and investment. By serving a wide range of clients, we use our expertise to influence every stakeholder involved in integrated care.

We are proud to have supported investors and operators to innovate, question the status quo and deliver improved health outcomes with clinical rigour. We enjoy working with clients who share our passion for “improving lives”.

Tell us more about the services that make Candesic stand out from the competition?

Our projects depend on rigour, rapid turnaround time, large data analysis, intensive primary research and the ability to be a trusted advisor. We combine this with true sector expertise and deep-rooted healthcare and academic knowledge. Our consultants and experts work together with our clients – both investors and corporates – and collectively find solutions.

What is your opinion on the impact of the current pandemic on the global healthcare sector, and how has Candesic fared during the pandemic and subsequent lockdowns?

The level of interest to invest in healthcare sky-rocketed during the pandemic. The world saw the impact of being vaccinated and it’s been a joy to watch populations embrace research and development. From Candesic’s perspective, we have been busy delivering project work – true to our core values of ‘CEO level clarity, R&D level analysis’ and ensuring high-quality care is available to all. Our decades of deep sector knowledge mean that we can add measurable value, to improve patient care and deliver return on investment for clients.

In your opinion, what could be the future of the healthcare consulting services sector post the pandemic? And how are you strategizing Candesic’s operations for that future?

Healthcare consulting, I hope, will become even more data-driven. The internet of things and the consumerization of healthcare allows for large data sets and patterns to be spotted. I’m excited to tie consulting to patient-level impact together, on a global scale.

As an established leader, what would be your advice to the budding entrepreneurs and enthusiasts aspiring to venture into the healthcare consulting services sector?

Health and care are a lifetime of dedication. Budding entrepreneurs are all welcome to bring a multi-disciplinary approach and new business ideas to complex problems. But it’s not a quick-buck sector and companies must have evidence-based before they have the right to expand.

How do you envision scaling Candesic’s operations in 2023?

Candesic’s beating heart is the amazing team who work here. We are growing globally alongside bringing a human heart to big data projects. When you work across life sciences, health and care it’s vital to link how innovation and change can improve patient outcomes. I’m proud every day to work in a multidisciplinary, diverse and multilingual environment and see our work impact personalized healthcare.

About the Leader

Dr Michelle Tempest was originally a frontline medical doctor and worked for over a decade in acute hospitals. She moved into healthcare consulting with a passion to integrate care across hospital, community, and home care and develop more joined-up services. As a strategy consultant, she works across life sciences, healthcare, social care and the digital, tech, device sectors. She has written a book about AI (The Big Brain Revolution: Artificial Intelligence – Spy or Saviour) and invests in digital start-ups. She enjoys working at the cutting edge of science to help democratize research into real-world health innovations.